Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver

Kevin Fiscella¹, Sarah E Wakeman², Leo Beletsky^{3

4}

Affiliations

¹ Departments of Family Medicine and Public Health Sciences, University of Rochester Medical Center, Rochester, New York.
² Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.
³ School of Law and Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts.
⁴ University of California San Diego School of Medicine, La Jolla.

Kevin Fiscella et al. JAMA Psychiatry. 2019.

. 2019 Mar 1;76(3):229-230.

doi: 10.1001/jamapsychiatry.2018.3685.

Kevin Fiscella¹, Sarah E Wakeman², Leo Beletsky^{3

4}

¹ Departments of Family Medicine and Public Health Sciences, University of Rochester Medical Center, Rochester, New York.
² Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.
³ School of Law and Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts.
⁴ University of California San Diego School of Medicine, La Jolla.

No abstract available

MeSH terms